High TNF-α levels in resting B cells negatively correlate with their response

Agrawal, 2011, TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors, J. Clin. Immunol., 31, 89, 10.1007/s10875-010-9456-8

Ahmed, 1995, Reduction in mortality associated with influenza vaccine during 1989–90 epidemic, Lancet, 346, 591, 10.1016/S0140-6736(95)91434-X

Biagi, 2010, Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians, PLoS One, 5, e10667, 10.1371/journal.pone.0010667

Biagi, 2011, The aging gut microbiota: new perspectives, Ageing Res. Rev., 10, 428, 10.1016/j.arr.2011.03.004

Bryl, 2001, Down-regulation of CD28 expression by TNF-alpha, J. Immunol., 167, 3231, 10.4049/jimmunol.167.6.3231

Deans, 2010, Influenza vaccines provide diminished protection but are cost-saving in older adults, J. Intern. Med., 267, 220, 10.1111/j.1365-2796.2009.02201.x

Duddy, 2007, Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis, J. Immunol., 178, 6092, 10.4049/jimmunol.178.10.6092

Ferrucci, 1997, Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled, JAMA, 277, 728, 10.1001/jama.1997.03540330050034

Festa, 2002, Insulin Resistance Atherosclerosis, S. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study, Diabetes, 51, 1131, 10.2337/diabetes.51.4.1131

Fiore, 2010, Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, MMWR Recomm. Rep., 59, 1

Franceschi, 2007, Inflammaging as a major characteristic of old people: can it be prevented or cured?, Nutr. Rev., 65, S173, 10.1301/nr.2007.dec.S173-S176

Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann. N. Y. Acad. Sci., 908, 244, 10.1111/j.1749-6632.2000.tb06651.x

Franceschi, 2000, The network and the remodeling theories of aging: historical background and new perspectives, Exp. Gerontol., 35, 879, 10.1016/S0531-5565(00)00172-8

Franceschi, 2007, Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans, Mech. Ageing Dev., 128, 92, 10.1016/j.mad.2006.11.016

Frasca, 2011, Aging affects human B cell responses, J. Clin. Immunol., 31, 430, 10.1007/s10875-010-9501-7

Frasca, 2008, Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells, J. Immunol., 180, 5283, 10.4049/jimmunol.180.8.5283

Frasca, 2010, Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans, Vaccine, 28, 8077, 10.1016/j.vaccine.2010.10.023

Frasca, 2011, Age effects on B cells and humoral immunity in humans, Ageing Res. Rev., 10, 330, 10.1016/j.arr.2010.08.004

Frasca, 2012, Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine, Int. Immunol., 24, 175, 10.1093/intimm/dxr123

Frasca, 2012, A molecular mechanism for TNF-alpha-mediated downregulation of B cell responses, J. Immunol., 188, 279, 10.4049/jimmunol.1003964

Frasca, 2013, Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine, Vaccine, 31, 3603, 10.1016/j.vaccine.2013.05.003

Goodwin, 2006, Antibody response to influenza vaccination in the elderly: a quantitative review, Vaccine, 24, 1159, 10.1016/j.vaccine.2005.08.105

Griffin, 2006, Inflammation and neurodegenerative diseases, Am. J. Clin. Nutr., 83, 470S, 10.1093/ajcn/83.2.470S

Gross, 1995, The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature, Ann. Intern. Med., 123, 518, 10.7326/0003-4819-123-7-199510010-00008

Himmerich, 2006, TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population, Eur. Cytokine Netw., 17, 196

Isaacs, 2009, Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists, Expert. Opin. Biol. Ther., 9, 1463, 10.1517/14712590903379494

Ito, 1997, Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species, Virology, 227, 493, 10.1006/viro.1996.8323

Keitel, 1988, Efficacy of sequential annual vaccination with inactivated influenza virus vaccine, Am. J. Epidemiol., 127, 353, 10.1093/oxfordjournals.aje.a114809

Khurana, 2012, AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans, PLoS Pathog., 8, e1002920, 10.1371/journal.ppat.1002920

Kimble, 1995, Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period, Endocrinology, 136, 3054, 10.1210/endo.136.7.7789332

Lazuardi, 2005, Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes, Immunology, 114, 37, 10.1111/j.1365-2567.2004.02006.x

Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323

Libby, 2006, Inflammation and cardiovascular disease mechanisms, Am. J. Clin. Nutr., 83, 456S, 10.1093/ajcn/83.2.456S

Loerbroks, 2011, Influenza vaccination coverage among high-risk groups in 11 European countries, Eur. J. Pub. Health, 22, 562, 10.1093/eurpub/ckr094

McElhaney, 2011, Influenza vaccine responses in older adults, Ageing Res. Rev., 10, 379, 10.1016/j.arr.2010.10.008

Monto, 2009, Influenza control in the 21st century: optimizing protection of older adults, Vaccine, 27, 5043, 10.1016/j.vaccine.2009.06.032

Murasko, 2002, Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly, Exp. Gerontol., 37, 427, 10.1016/S0531-5565(01)00210-8

Panda, 2010, Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response, J. Immunol., 184, 2518, 10.4049/jimmunol.0901022

Parish, 2009, Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3, J. Immunol., 182, 4237, 10.4049/jimmunol.0803449

Pawelec, 2009, Cytomegalovirus and human immunosenescence, Rev. Med. Virol., 19, 47, 10.1002/rmv.598

Pawelec, 2010, Immunosenescence and Cytomegalovirus: where do we stand after a decade?, Immun. Ageing, 7, 13, 10.1186/1742-4933-7-13

Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327

Sansoni, 2008, The immune system in extreme longevity, Exp. Gerontol., 43, 61, 10.1016/j.exger.2007.06.008

Sarzi-Puttini, 2005, Tumor necrosis factor-alpha, biologic agents and cardiovascular risk, Lupus, 14, 780, 10.1191/0961203305lu2220oa

Shi, 2005, Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell, J. Immunol., 175, 3262, 10.4049/jimmunol.175.5.3262

Simonsen, 1998, Pandemic versus epidemic influenza mortality: a pattern of changing age distribution, J. Infect. Dis., 178, 53, 10.1086/515616

Simonsen, 2007, Mortality benefits of influenza vaccination in elderly people: an ongoing controversy, Lancet Infect. Dis., 7, 658, 10.1016/S1473-3099(07)70236-0

Solana, 2006, Aging and innate immunity, Immunity, 24, 491, 10.1016/j.immuni.2006.05.003

Sridharan, 2010, Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity, Age (Dordr), 33, 363, 10.1007/s11357-010-9191-3

Vallejo, 2005, CD28 extinction in human T cells: altered functions and the program of T-cell senescence, Immunol. Rev., 205, 158, 10.1111/j.0105-2896.2005.00256.x

Vu, 2002, A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community, Vaccine, 20, 1831, 10.1016/S0264-410X(02)00041-5

Zimmerman, 2010, Prevalence of high-risk indications for influenza vaccine varies by age, race, and income, Vaccine, 28, 6470, 10.1016/j.vaccine.2010.07.037